INO

#3500
Inovio Pharmaceuticals, Inc. - Common Stock
1.3 1 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
1.31
1.31
Year Range
1.03
2.98
Daily Change
0.00%
Monthly Change
+15.93%
6 month change
-36.41%
Year Change
-38.21%
Previous Close
1.3 1
Open
1.3 1
Low
1.3 1
High
1.3 1
Volume
36
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

Inovio Pharmaceuticals, Inc. - Common Stock

Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development.

News